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Tumorigenic transformation of human epithelial cells in vitro has been described ex-
perimentally as the potential result of a process known as spontaneous immortalization.
In this process a generic series of cell–state transitions occur in which normal epithelial
cells acquire a senescent state, later surpassed to attain first a mesenchymal state and
then a final mesenchymal stem–like phenotype, with potential tumorigenic behavior. In
this paper we integrate published data on the molecular components and interactions
that have been described as key regulators of such cell states and transitions. A large
network, that is provided, is constructed and then reduced with the aim of recovering a
minimal regulatory core incorporating the necessary and sufficient restrictions to recover
the observed cell states and their generic progression patterns in epithelial–mesenchymal
transition. Data is formalized into logical regulatory rules that govern the dynamics
of each of the network’s components as a function of the states of its regulators. The
proposed core gene regulatory network attains only three steady–state gene expression
configurations that correspond to the profiles characteristic of normal epithelial, senes-
cent, and mesenchymal stem–like cells. Interestingly, epigenetic landscape analyses of
the uncovered network shows that it also recovers the generic time–ordered transitions
documented during tumorigenic transformation in vitro of epithelial cells. The lat-
ter strongly correlate with the patterns observed during the progressive pathological
description of epithelial carcinogenesis in vivo.
Introduction
Nearly 84% of cancers diagnosed in human adults are carcinomas (i.e., cancer of epithelial ori-
gin), and their emergence is strongly associated with both an underlying chronic inflammatory
process and with aging [1]. The precise role and the contribution of these two processes to the
origin, progression, and detected clinic behavior of epithelial cancers remains elusive, however. The
current general assumption is that aging and inflammation increase the chance of accumulating
somatic mutations, and this genetic instability ultimately leads to carcinoma. However, this view
does not offer a logical or mechanistic explanation for well–documented observations. For example:
(1) cancer cells show morphological and transcriptional convergences despite their diverse origin,
(2) carcinogenesis recapitulates embryonic processes, (3) cancer behavior can be acquired in the
absence of mutations through trans– or dedifferentiation, and (4) cancer cells can be “normalized”
by several experimental means [2–5]. Moreover, it is well–known that different carcinomas share
the same cellular processes and histological stages or progression patterns, as well as robust asso-
ciations with lifestyle factors [6]. These empirical observations suggests that, in analogy to normal
development, the human genome is associated with an underlying robust mechanism restricting cell
states and temporal progression patterns that are characteristic of epithelial carcinogenesis. In ac-
cordance with this view, other researchers have previously proposed that cancer can be considered
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a developmental disease [7, 8].
In systems biology it is common to understand both cell differentiation and development in terms
of dynamical systems theory. In this framework, the genome of a cell is directly mapped into a global
and multi–stable gene regulatory network (GRN) whose dynamics yields several (quasi)stationary
and stable distinct phenotypic cellular states [9–14]. That is, the same genome robustly generates
multiple discrete cellular phenotypes through developmental dynamics [12, 15, 16]. These stable
phenotypic states are called attractors and correspond to configurations of gene or protein activa-
tion states that underlie the cellular fates or phenotypes – i.e., which thus constitute biological
observables. Therefore, developmental processes – cellular differentiation events in particular –
are formalized in temporal terms as attractor’s (i.e., cell states) transitions. Here we adopt such
approach to study the cell states attained and the time–ordered transitions observed during the
tumorigenic transformation of epithelial cells cultured in vitro that surpass a senescent state; a
process known as spontaneous immortalization.
Experimental findings in molecular and cell biology of cancer research have revealed that it is
possible to recover cells with cancer–like phenotypes through some specific cellular transitions.
This has been shown particularly in carcinomas [3, 17–19]. By a cellular transition we refer to a
differentiation event in which a certain cell acquires a discretely different cellular phenotype. For
example, the process called epithelial–mesenchymal transition (EMT) comprises a stereotypical
cell state transition in which epithelial cells exposed, for example, to cytokines, are induced to
undergo a discrete phenotypic change acquiring a mesenchymal phenotype [17, 19]. Interestingly,
through inflammation–induced EMT epithelial cells surpass senescence, and undergo spontaneous
immortalization. Cells that emerge from this process manifest mesenchymal stem–like properties
and are capable of developing cancer in murine models [3,18]. Furthermore, these cells are difficult
to distinguish phenotypically and in terms of the transcription factors that they express from ei-
ther the so–called cancer stem cells (also known as tumor initiating cells) or from embryonic stem
cells [20, 21].
In the present work, we hypothesize that a generic series of cell state transitions widely observed
and robustly induced by inflammation in cell cultures during spontaneous immortalization naturally
result from the self–organized behavior emerging from an underlying intracellular GRN. During this
process, normal epithelial cells first acquire a senescent state, to finally attain a mesenchymal stem–
like cellular state with a potential tumorigenic behavior. We speculate that tissue–level conditions
associated with a bad prognosis, such as a pro–inflammatory milieu, may increase the rate of oc-
currence of these same transitions in vivo promoting as a result the emergence and progression of
epithelial cancer.
In an attempt to provide mechanistic insights into the regulation of the aforementioned observed
cell–fates specification, as well as the time–ordered cell–state transitions, we propose here a cellular
level GRN model that integrates the available experimental data concerning the main molecular
components and interactions related to the emergence and progression of carcinomas. We propose
a large GRN of 41 nodes that integrates cellular processes thoroughly studied experimentally, but
which have not been integrated before into a single GRN. Specifically, the large GRN model includes
key molecular regulators that: (1) characterize the cellular phenotypes of epithelial, mesenchymal,
and senescent cells; (2) are involved in the induction of the cellular processes of replicative senes-
cence, cellular inflammation, and EMT; and (3) characterize the phenotypic changes undergone
by cells emerging from these processes (i.e. mesenchymal stem–like cells). To obtain a minimal
regulatory core for further dynamical analyses we formally reduced the large GRN. We show that
the proposed regulatory core module displays an orchestrating robust behavior akin to that seen in
other developmental regulatory modules previously characterized with similar formal approaches
(see, for example [9, 10, 22, 23]). Specifically, by proposing logical functions grounded on experi-
mental data for this regulatory core module and by analyzing its behavior following conventional
Boolean GRN dynamical approaches, we show that the uncovered minimal GRN converges only to
three attractors. The uncovered states correspond to the expected gene expression configurations
that have been observed for normal epithelial, senescent and stem–like mesenchymal cellular fates.
Additionally, we also explore the GRN Epigenetic Landscape using a stochastic version of the model
(following: [24, 25]) in order to address if the proposed GRN also restricts or underlies the generic
temporal sequence with which cell states occur in cell cultures and which correlate with observed
patterns of cell–type enrichment during pathological descriptions of carcinoma progression.
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Results
Gene Regulatory Network Construction
Following a bottom–up and an expert knowledge approach we propose a set of cellular dynamical
processes ubiquitous to epithelial carcinogenesis, namely: replicative cellular senescence, inflamma-
tion, and epithelial–mesenchymal transition (EMT). The cellular phenotypes epithelial, senescent,
and mesenchymal cell–types – as well as a mesenchymal embryonic–like state; have been largely
characterized as biological observables involved in such processes. We provide further definitions
of these – and associated – phenotypes and processes in our complementary Text S1. We take this
information as a methodological basis to integrate a generic dynamical network model of epithelial
carcinogenesis. As a first step in network integration, based on an extensive literature search (see
Methods and Text S1), we assembled a set of transcription factors (TFs) and additional molecules
involved in the establishment and regulation of these cellular states and processes. Subsequently,
we manually retrieved documented regulatory interactions among the molecules, considering only
those supported by experimental evidence. For a detailed description of the published information
for each interaction proposed see Text S1. The constructed large GRN is shown in Figure 1 (see
Methods). TFs are represented in graphical terms by squares and the rest of the molecules by
circles. The identified large network consists of 41 nodes and 97 interactions; it includes 12 TFs
which can be considered as key regulators of the processes under consideration. Colors indicate
the association that each node hold with specific cellular phenotypes or processes being considered:
epithelial (green), mesenchymal (orange), inflammation (red), senescence and DNA damage (blue),
cell–cycle (purple), and polycomb complex (yellow).
The Proposed Network is Enriched with Cancer Pathways
In order to provide additional partial support for the association of the bio-molecular set of reg-
ulatory interactions that we have manually curated based on published data with the processes
under consideration, as well as with carcinoma, we performed a network–based gene set enrich-
ment analysis (GSEA) (see Methods). Among the 13 pathways or processes reported as significant
when taking the KEGG database as a reference, 9 (69%) correspond to cancer pathways, namely:
Bladder cancer, Chronic myeloid leukemia, Pancreatic cancer, Glioma, Non–small cell lung can-
cer, Melanoma, Small cell lung cancer, Prostate cancer, and Thyroid cancer – note that 6 (66.6%)
of these correspond to carcinomas. On the other hand, when taking the GO Biological Process
database as reference, among the significant results we found: replicative senescence, cellular senes-
cence, cell aging, activation of NF–κB–inducing kinase activity, determination of adult life span,
epithelial cell differentiation, and positive regulation of NF–κB transcription factor activity (see
Table 1). Using network topological gene set analysis (see Methods) we found that, in addition to
pathway enrichment, the topological signature of the molecules in the proposed network also shows
a topological signature that is similar to the one shown by reference cancer pathways included
in the KEGG database (see Figure S1). These results provide partial support for the proposed
molecular players: given the current state of knowledge according to annotated databases, the set
of molecules manually included in the proposed large network seems to be representative of the
cellular phenotypes and processes considered as prior biological knowledge in our model. In addi-
tion, the molecular components included in the proposed large network are tightly associated with
reference pathways of epithelial cancers.
A Core Regulatory Network Module Underlying Spontaneous Immortalization
We performed a knowledge–based network reduction of the large GRN in Figure 1 in order to
derive a smaller, core GRN module for which both a topology and architecture with fully defined
logical functions could be established, and which could also be analyzed as a dynamical system
(see Methods). In addition, such regulatory core should comprise the necessary and sufficient set
of nodes and interactions that integrate the processes involved in the large network and that could
explain, at least in part, the restricted set of the cell–states and time–ordered transitions among
them during spontaneous immortalization and epithelial cancer emergence/progression. We were
able to define a set of molecular species whose regulatory hierarchy, activity, and expression define
the identity of the phenotypes of epithelial, mesenchymal, and senescent cells. We also converged
to, and included, main regulators of replicative cellular senescence, inflammation–induced EMT,
and determinants of an induced mesenchymal stem–like phenotype. Hence, after reduction we
obtained a core GRN consisting of only 9 nodes: ESE–2, Snai2, NF–κB, E2F, p53, p16, Rb,
Cyclin, and Telomerase. Figure 1b shows the proposed core regulatory module (colored nodes) in
the context of the larger proposed network. For details on how these 9 nodes were selected over the
rest of the nodes see Text S1. In what follows we present a brief description of the nodes included
in the reduced GRN, as well as some of the key molecular mechanism encoded in the regulatory
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logic. Although many of the nodes that are included in this regulatory core module have been
thoroughly studied experimentally and in terms of their involvement in different types of cancer,
the architecture and topology of the proposed regulatory core module is novel.
ESE–2 represents the activity of the TFs ESE–1, ESE–2, and ESE–3 (also known as ESX, E74–like
factor 5, and EHF; respectively) – for a table with synonyms Table E1 in supplementary file.
These proteins belong to the subgroup ESE (i.e. epithelium–specific) of the TF family ETS.
ESE–2 promotes its own expression and the expression of the other ESE TFs [26–28]. On the
other hand, ESE–2 represses Snai2 – one of the main EMT promoting TFs – expression by
direct interaction with its promoter region [29].
p16 represents the activity of the INK4b–ARF–INK4a locus, which encodes for the proteins p16
and p14. Cellular senescence is molecularly characterized by the expression of the proteins p16
and p53 [30]. p16 indirectly inhibits E2F by inhibiting cyclins CDK 2,4 and 6, which in turn
inhibit Rb [31,32]. On the other hand, the INK4b–ARF–INK4a – and thus p16 – is regulated
by the activity of Polycomb–group proteins by means of promoter hypermethylation [33].
p53 represents the protein with the same name. The shortage of telomeric DNA seems to be
recognized as DNA damage promoting the activation of p53. In senescence, the activity
of p16 and p53 over Rb, E2F and Cyclins invariably arrests the cell–cycle in the phase
G1/G2 [34,35].
Rb represents the cell–cycle regulator with the same name. Rb prevents cycle progression by
forming a complex with the TF E2F [36].
E2F represents the TF with the same name. E2F regulates critical genes for adequate cell–cycle
progression.
Cyclin represents the activity of the complex Cyclin–dependent kinases (CDKs) known to inactivate
Rb by phosphorylation. The latter, in turn, promotes the activity of E2F and cell–cycle
progression [37].
NF-κB represents cellular inflammation by the activity of the TF NF–κB. Accordingly, with this
node we also represent the effect of the cytokines transforming growth factor–beta (TGF–β),
interleukin–6 (IL–6), and tumor necrosis factor alpha (TNF–α). These three factors converge
in the activation of NF–κB by phosphorylating the inhibitor IκB [38,39].
TELasa represents the enzyme telomerase. This enzyme is responsible for the de novo synthesis
of telomeres. Most human cell–types do not express telomerase; however, it is expressed on
immortalized epithelial cells, and it is thought to be responsible for telomere extension in
tumors [40].
Snai2 this node includes the activity of the main TFs known to be directly associated with EMT
regulation, namely: Snai2 (Slug), Snail, Twist1, Twist2, ZEB1, ZEB2, and FOXC2. These
TFs repress (induce) the expression of genes specific to epithelial (mesenchymal) cells [41,
42]. It has been proposed that there is a regulatory hierarchy driving EMT in which Snail
activates Snai2, Twist, Zeb, and FOXC2. The latter, in turn, regulates Snail and Snai2 in a
positive manner [41,43–45]. Regardless of a hierarchical interpretation, it is well–documented
that these TFs maintain the mesenchymal phenotype in a coordinated fashion, showing co–
expression patterns and regulatory crosstalk [44,45]. It has been suggested that among these
TFs, Snai2 may be the strongest suppressor of the epithelial phenotype [46]. However, we
decided to represent the collective regulatory activity of the mesenchymal TFs using Snai2
based on the recent experimental demonstration of an antagonistic relation between Snai2 and
ESE–2. Specifically, in vitro and in vivo studies showed that ESE–2 regulates the transcription
of Snai2 [29].
According to our model reduction methodology, literature search, careful manual curation, and
network–based enrichment analysis; we propose that the derived core GRN module (see Figure
2) includes a molecular set which is both necessary and sufficient to specify the identity of the
aforementioned cellular phenotypes and to represent the main intracellular regulatory events driving
spontaneous immortalization in a robust manner. We test our proposal by building and analyzing
a mechanistic GRN dynamical model (see below).
Recovered Attractors of the Core GRN Module Correspond to Configurations that
Characterize Expected Cellular Phenotypes
Based on the experimental data concerning the expression patterns of the genes incorporated in
the proposed core GRN model in Figure 2 we assembled a table with a Boolean format of the state
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configurations expected to be recovered with the proposed GRN dynamical model. We refer to this
configurations as the “expected attractors” – these correspond to the empirically observed genetic
configurations. Furthermore, we integrated and formalized the experimental data concerning the
interactions among the GRN nodes using Boolean logical functions that will rule the Boolean GRN
dynamics and comprise the architecture of the proposed GRN. The set of formulated rules under-
lying the regulatory events is shown in Text S1 – each logical rule is presented both as a logical
preposition and as a truth table. Using the set of nodes and their corresponding logical rules we
completely define a mechanistic dynamical GRN model [47]. The exhaustive computer–based sim-
ulation analysis of this model (see Methods) recovered three fixed–point attractors. Interestingly,
the recovered attractors showed perfect correspondence with the expected attractors represent-
ing cellular phenotypes (see Table 2). The three recovered attractors correspond to the expected
epithelial, senescent, and mesenchymal stem–like phenotypes :
The normal epithelial cell phenotype is represented by the attractor with ESE–2, E2F, Cyclin
and NF–κB activity. ESE–2 is an epithelial–specific TF which regulates a large number of genes
specific to epithelial cells [48, 49]. NF–κB shows ubiquitous expression through the different types
of human cells; however, it is also positively regulated by TFs of the ESE family (i.e. ESE–2) [50].
Moreover, under inflammatory conditions the activity of NF–κB is enhanced [51,52]. On the other
hand, E2F and Cyclin represent core regulators of cell–cycle entrance, and thus specify proliferative
capability [53,54].
The senescent cell phenotype is represented by the attractor with ESE–2, Rb, p16, p53, and NF–
κB activity. Its biological counterpart would be an epithelial cell induced to replicative senescence,
given (1) that it is expected to repress E2F [48]; and (2) that Rb, p16, p53, and NF–κB are the
molecular biomarkers of cellular senescence [55].
Messenchymal Stem-like phenotype In the model proposed here, the attractor whose configura-
tion shows Snai2, Cyclin, NF–κB, and Telomerase activity – and inactivity of ESE–2, p16, Rb, p53,
and E2F – would correspond to a mesenchymal stem–like phenotype with tumorigenic potential
(see discussion below).
The correspondence between the recovered attractors and the expected cellular phenotypes
strongly suggests that the proposed nine–node core GRN indeed constitutes a regulatory module
that is robust to initial conditions and that comprises a set of necessary and sufficient components
and interactions to restrict the system to converge to the cellular phenotypes observed during
spontaneous immortalization.
Validation of the Uncovered Core Regulatory Module: Loss and gain–of–function
Mutant and Robustness Analyses
In order to validate the Boolean GRN dynamics we tested if the same GRN module is able to recover
observed attractors in loss and gain of function mutants. We simulated such mutants analogous
to experimental observations reported in the literature. Specifically, we simulated loss– and gain–
of–function mutations of ESE–2, Snai2, and p16 that have been reported in the literature. When
simulating ESE–2 gain of function (by setting the expression state for this node permanently to “1”
in the simulations), the GRN model recovers three attractors corresponding to three different phe-
notypes which have been experimentally described and are associated with ESE–2 over–expression:
an epithelial senescent cell [56], a normal epithelial cell [29], and a metastable state with prolifera-
tive phenotype [57]. In the case of ESE–2 loss–of–function (simulated by setting the expression state
of this node to “0” permanently), the model recovers an attractor corresponding to a mesenchymal
phenotype, which is also consistent with observations [29]. For Snai2, gain–of–function simula-
tion recovers one attractor corresponding to mesenchymal stem–like phenotype, which is consistent
with observations from ectopic over–expression experiments of mesenchymal TFs [18,58,59]. Snai2
loss–of–function simulation, on the other hand, recovered two attractors corresponding to normal
and senescent epithelial phenotypes, which is also consistent with observations [29, 60]. Finally,
gain–of–function simulation of p16 recovered two attractors; one associated with a mesenchymal
stem–like but incompletely senescent (due to the lack of p53) phenotype; the other corresponding
to an epithelial senescent phenotype. The first prediction is consistent with the status of immortal
and apoptosis–resistant shown by mesenchymal stem–like cells, as well as with the capability of
mesenchymal TFs to abrogate senescence [61]. The second attractor is consistent with the potential
for replicative senescence of epithelial cells. p16 loss–of–function simulation recovers two attractors
corresponding to an epithelial cell and a mesenchymal stem–like cell. This prediction is consistent
with the observed biological conditions for both phenotypes, where p16 is commonly repressed by
polycomb proteins [62]. The recovered attractors in mutant conditions are shown in Figure S2 in
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supplementary file.
It is important to note that, given that the uncovered regulatory module uncovered here is
the result of a model reduction methodology where we permissively chose to represent multiple
molecular species by the activity of some of the nodes, a direct interpretation of mutant simulations
is not straightforward. Consequently, care should be taken when interpreting the results of the
simulations or making predictions of mutant phenotypes yet to be experimentally tested and further
explored in the context of the larger GRN in Figure 1, which is the focus of an ongoing study.
With this in mind, instead of simulating additional mutant conditions, we further validated the
dynamical GRN model by testing its robustness to perturbations of the logical rules. Specifically,
we tested the robustness of the predicted attractors by generating a large set of perturbed networks
(e.g, 10,000), calculating their respective attractors, and then counting the occurrences of the
original attractors within the perturbed set. We generated each perturbed network by choosing a
function of the network at random and flipping a single bit in this function [63]. We performed four
complementary in silico based experiments following this general robustness analysis. First, we
estimated the fraction of occurrences of the three original attractors (i.e., their robustness). Then,
we repeated the experiment three times, but each time estimating the robustness of each individual
attractor. For these four experiments we estimated a robustness (i.e., fraction of times) of 0.7439,
0.905, 0.923, and 0.902, respectively. Hence, out of 10,000 random networks generated by in silico
perturbations to the logical rules, a major fraction recovered the original attractors; as it is expected
for a developmental (core) regulatory module that is robust both to transient (initial) and genetic
perturbations [10]. This result supports the view that the core GRN uncovered here is indeed
a regulatory network module driving developmental dynamics. It also constitutes a mechanistic
explanation (for definitions, see [47]) to the generic cell phenotypes observed during spontaneous
immortalization in vitro and which correlate with the cellular description of carcinoma progression
in vivo (see below).
Attractor Time–Ordered Transitions: Epigenetic Landscape of the Uncovered GRN
Core Module
During the tumorigenic transformation of epithelial cells in culture, a generic time–ordered series of
cell state transitions is observed and robustly induced by inflammation [3,18]. Normal epithelial cell
become senescent cells, which afterwards overcome this latter state acquiring a final mesenchymal
stem–like phenotype. Interestingly, during the progressive pathological description of epithelial
carcinomas in vivo the temporal pattern with which each of these different cell phenotypes enriches
the tissue seems to be tightly ordered and is also generic to all types of such cancers irrespective
of the tissue where they first appear. In order to test if the uncovered GRN core module not
only underlies and restricts the types of cell phenotypes (attractors) but also their time–ordered
transitions, following [25] we explored its associated Epigenetic Landscape (EL) by implementing
a discrete stochastic model as an extension to the Boolean network model [12] (see Methods). By
means of computer–based simulations we performed two analyses in order to uncover functional
and structural constraints in attractor transitions. (1) We explored the temporal sequence of
attractor attainment, and (2) we calculated the consistent global ordering of all the given attractors.
Specifically, following [24], we found that the most probable temporal order of attractor attainment
for a cell (population) initially on epithelial state is:
Epithelial→ Senescent→ Mesenchymal stem–like,
see Fig 4a. On the other hand, following [64] we defined a consistent global ordering of the un-
covered attractors based on their relative stability (see Methods). Relative stability calculations
are based on the mean first passage time (MFPT) between pairs of attractors. These, in turn,
epitomize barrier heights in the EL by approximating a measure for the ease of specific transi-
tions. Similar to the previous analysis, the uncovered global ordering of attractors is Epithelial →
Senescent → Mesenchymal stem–like (Fig 4b). This corresponds to the only order in which the
system can visit the three attractors following a positive net transition rate. These results indicate
that, when considering only intracellular regulatory constraints alone, the uncovered GRN core
module structures the epigenetic landscape in a way that a specific flow across the landscape is
preferentially and robustly followed. We anticipate that observed transition rates in vivo are likely
to depend on tissue–level processes and/or additional GRN components underlying epithelial cell
sub–differentiation, that have not been considered here. These latter restrictions will be modeled
in future contributions building up on the framework that has been put forward here.
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Discussion
Multicellularity by definition implies a one–to–many genotype–phenotype map. The genome of a
multicellular individual possesses the intrinsic potentiality to implement a developmental process
by which all its different cell–types and tissue structures are ultimately established. In the last
decades, a quite coherent theory to explain the development of multicellular organisms as the
result of the orchestrating role of GRNs has been developed [9, 11, 12]. The main conclusion is
that observable cell states emerge from the self–consistent multistable regulatory logic dictated by
genome structure and obeyed by (mainly) transcription factors (TFs) resulting in stable, steady–
states of gene expression. Cancer development and progression is also a phenomenon intrinsic to
multicellular organisms. Furthermore, similar to normal development, cancer is robustly established
as evidenced by its directionality and phenotypic convergence [2]. Is cancer somehow orchestrated
by GRN dynamics as well? Several hypothesis have been presented in this direction such as the
cancer attractor theory [2,8], and the endogenous molecular cellular network hypothesis [65,66]. In
this contribution we also follow the viewpoint of an intrinsic regulatory network, but we focus on a
specific developmental process at the cellular level: the robust cell state transitions observed during
the tumorigenic transformation of human epithelial cells in culture induced by inflammation and
resulting from surpassing a senescent state through EMT – i.e., tumorigenic transformation due to
spontaneous immortalization. We propose that a mechanistic understanding of this process is an
important first necessary step to unravel key cellular processes which might be occurring in vivo,
where its rate of occurrence is likely to be regulated by tissue–level and systemic conditions directly
linked with lifestyle choices, as well as additional regulatory interactions underlying epithelial cell
sub–differentiation.
A Generic Molecular Regulatory Network
The predominant strategy in the molecular study of cancer and cellular tumorigenic transformation
has been to focus on pathways and associated mutations. Aware that signaling pathways are actu-
ally embedded in complex regulatory networks here we assembled from curated literature a GRN
comprising the main molecular regulators involved in key cellular processes ubiquitous to carcino-
genesis following a bottom–up approach (see results). Subsequently, we followed a mechanistic
approach to address the question of whether we assembled a set of necessary and sufficient molec-
ular players and interactions to recover the cellular phenotypes and processes documented during
the spontaneous immortalization of human epithelial cells in culture: we proposed, analyzed and
validated an experimentally grounded core GRN dynamical model.
Small developmental regulatory modules have been shown to successfully include the necessary
and sufficient set of components and interactions for explaining, as manifestations of intrinsic struc-
tural and functional constraints imposed by these GRNs, the dynamics of complex processes such
as stem cell differentiation [67], cell–fate decision [68] and similar cellular processes during plant
morphogenesis [9, 10, 22, 24]. We hypothesized that a similar core developmental module can be
formulated in an attempt to explain the cell–fates observed during spontaneous immortalization
of human epithelial cells in vitro resulting in a potentially tumorigenic state. In order to show
this, we first reduced the proposed larger network into a regulatory core module, by eliminating
transitory pathways within the network and by including compounded nodes while maintaining
the core network structure and without affecting the dynamical output during each reduction step
(for details, see Methods). We obtained a small set of main molecular players (Fig 2). We ex-
tracted from available literature the expression profiles of the generally observable cell states of
interest in terms of this minimal set of molecules (see Table 2). Given our main hypothesis, we
tested if the reduced molecular set and their regulatory logic formalized as a Boolean GRN model
were able to recover the biologically observable expression profiles as stationary and stable network
configurations (i.e., attractors). Interestingly, we found that the core GRN model only converges
to the observed gene expression profiles in wild–type (see Table 2) and some mutant backgrounds
(see results). This result strongly suggest that we have successfully included the key regulators
and interactions at play during the establishment of cell states observed during the tumorigenic
transformation of human epithelial cells resulting from spontaneous immortalization.
It is noteworthy that our model does not include any hypothetical interaction or component, a
common practice in GRN modeling [10, 22, 68]. Our GRN model exclusively integrates available
published experimental data; indeed, it was a surprising result that the observed dynamical behav-
ior emerged naturally under such conditions. This suggests that despite incomplete information,
there is enough molecular data to uncover important restrictions underlying cell behavior during
transitions relevant to epithelial carcinogenesis. Consequently, we consider that the networks re-
ported herein (both the large and the core GRNs) may serve as bona fide base models useful to
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integrate novel discoveries, as well as components underlying epithelial cellular sub–differentiation,
while following a bottom–up approach in cancer network systems biology.
Attractor Time–Ordered Transitions
Discrete GRN models can be used to integrate regulatory mechanisms that not only recapitulate
the observed gene expression patterns, but that also reproduce the observed developmental time–
ordering of cell phenotypes. This can be done by considering stochasticity in the model in order
to explore [12, 23, 25] and/or characterize [64] the associated EL. Importantly, by exploring noise–
induced transitions we do not assume that noise alone is the driving force of the transitions, instead,
we exploit noise as a tool to explore the GRN–based version of Waddington’s EL and to indirectly
characterize its structure. Specifically, by calculating the relative stability of the attractors (see
Methods) we approximate the in–between attractor barrier heights in the landscape. Furthermore,
measures of relative stability can also be exploited to calculate net transition rates measuring
the ease of specific inter–attractor transitions and to uncover the predominant developmental route
across the epigenetic landscape [69]: ordered transitions sharing positive net transition rates will be
preferentially followed. Our results show that such a developmental route follows the time–order of
cellular phenotypic states epithelial→senescent→mesenchymal stem–like (potentially tumorigenic).
In other words, the constraints imposed by the GRN structure the associated EL in such a way
that an epithelial cell in culture as a “ball” would naturally roll following such a path, in agreement
with the observed spontaneous immortalization process.
Even in the case of the simple model presented here, it is interesting that of the many possible cell
states and developmental routes, the core GRN network is canalized to the few steady–states and
the developmental time–ordering consistent with the molecular characterization of cell phenotypes
observed during spontaneous immortalization and correlating with carcinoma progression in vivo
(see below). This suggests that specific progressive alterations or particular “abnormal” signaling
mechanisms are not necessarily required for a cell to reach a potentially tumorigenic state. Addi-
tionally, robustness analysis performed on the same network showed that the recovered attractors
are also robust to permanent alterations of the regulatory logic.
From Abstract Network Attractors and Dynamics to Biological Insight
We are aware of the high degree of simplification involved in the model proposed herein. Accord-
ingly, we do not attempt to present it as a source of accurate predictions for either the occurrence
or the future behavior of a phenomena as complex as carcinogenesis. Instead, we formulate the
model in an attempt to provide some intuition into otherwise highly complicated processes, and
to illuminate increasing body of confounding descriptions. Simple mechanistic models like the one
presented here sacrifice detail and accuracy in exchange for understanding [47,70]. What biological
insights can be gained by the uncovered GRN dynamical model? Our simple GRN model strongly
suggests that the generic series of cell state transitions widely observed and robustly induced by
inflammation in cell culture from normal epithelial to immortalized senescent cells, and from this
latter state to a final mesenchymal stem–like phenotype in the process defined as spontaneous im-
mortalization naturally result from the self–organized behavior emerging from an underlying GRN
novel architecture and topology.
Importantly, cells that emerge from spontaneous immortalization induced by cytokines display
mesenchymal stem like phenotype and tumorigenic behavior – i.e., repress proteins p16 and p53,
surpass senescence, and re–express telomerase [18]. Phenotypically, these cells are difficult to dis-
tinguish from the so–called cancer stem cells, tumor initiating cells or embryonic stem cells [20,21];
are resistant to apoptosis; and have the ability to migrate and generate metastasis and form sec-
ondary tumors – all lethal traits characterizing cancer cells [3]. We, thus, speculate that tissue–level
conditions associated with a bad prognosis, such as a pro–inflammatory milieu, may increase the
rate of occurrence of these same transitions in vivo promoting as a result the development and
progression of epithelial cancer. We substantiate this view by noting several independent empirical
observations. (1) Histological diagnosis of carcinoma are generally preceded by a lesion called hy-
perplasia; senescent cells are abundant in hyperplasias and scarce in carcinomas [71]. (2) During
chronological aging senescent cells increase in number within both normal tissues and hyperplasias.
(3) Senescence is associated with the promotion of carcinogenesis by contributing with the loss
of tissue architecture and promoting an inflammatory milieu [72]. (3) Overcoming the senescent
barrier is fundamental in tumor progression [73, 74]. (4) The EMT process constitutes a well–
characterized mean to overcome senescence under an inflammatory environment( [75]).
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We must point out, however, that transition rates during spontaneous immortalization, if occur-
ring in vivo, may be regulated by tissue–level, self–organizational processes not considered in our
cellular level model. For example, the likelihood of spontaneous immortalization in vivo may be
increased by extracellular perturbations that inevitably occur during aging; mainly, by inflamma-
tion and tissue remodeling resulting from an increased population of senescent cells. The cellular
level network models reported here are, nevertheless, a valuable building block for more detailed
multi–level models integrating further sources of tissue–level constraints such as cell cycle progres-
sion, cell–cell interactions, differential proliferation rates, and mechanical forces.
Summarizing, in this contribution we propose an experimentally grounded GRN model for spon-
taneous immortalization. We report one large GRN model (41 nodes) and one core GRN devel-
opmental module (9 nodes), both useful and necessary for further integration of signaling and
mechanical processes in multi–level, more detailed modeling efforts. We explore by analyzing the
dynamical behavior of the latter if the uncovered GRN topology and architecture underlies the
gene expression configurations that characterize normal epithelial, senescent, and mesenchymal
stem–like cell–fates well documented during tumorigenic transformation in vitro and which cor-
relate with those observed in the progressive pathological description of epithelial carcinogenesis
in vivo. Overall, our results suggest that tumorigenic transformation in vitro due to spontaneous
immortalization can be understood and modeled at a cellular level generically as a developmental
system undergoing cell–state transitions resulting from the structural and functional constraints
imposed, in part, by the interactions included in the proposed GRN. They also suggest that similar
transitions may be occurring in vivo and might be relevant for carcinoma development and pro-
gression. This view is consistent with the robustness, generic patterns, and directionality observed
during the development of human cancers derived from epithelial tissues. Particularly, based on our
results, we hypothesize that replicative senescence and chronic inflammation are likely to increase
the occurrence of spontaneous immortalization in vivo promoting the development of epithelial
carcinogenesis. Testing such hypothesis awaits the development of multi–level models taking the
ones presented here as building blocks, which is the subject of ongoing investigation.
Materials and Methods
Literature Search
A total of 159 references, considering both references in extended view material (see Text S1) and
main text, were carefully and manually reviewed in order to first define a minimal set of cellular
phenotypes and processes (for definitions, see Text S1) which enable a generic representation of
epithelial carcinogenesis on the basis of cell state transition events. Subsequently, a set of associated,
experimentally described molecular regulators was extracted from the literature, including their
regulatory interactions.
Network Assembly
The network (see Fig. 1) was assembled manually by adding nodes (genes/proteins) and edges (ac-
tivating or inhibitory interactions) describing direct mechanisms reported in the available literature
to have an influence on both the specification of the cellular phenotypes and the development of
the cellular process defined in (Text S1). The initial network was created based on experimentally
grounded knowledge from 159 references (including reviews and research papers) and consists of
41 nodes and 97 edges. The literature included data known before 2014. Support for each of the
proposed interactions is listed in Text S1.
Network–based Gene Set Enrichment Analysis
The bioinformatics tools EnrichNet [76] and TopoGSA [77] were used to perform network–based
gene set enrichment analysis and topology–based gene set analysis, respectively. Briefly, EnrichNet
maps the input gene set into a molecular interaction network and calculates distances between the
genes and pathways/processes in a reference database. TopoGSA also maps the input gene set into
a network, and then it computes its topological statistics and compares it against the topology of
pathways/processes in a reference database. Here a connected human interactome graph extracted
from the STRING database and the KEGG and GO Biological Process databases were used as
reference molecular interaction network and databases. Both analyses were performed using the
Cytoscape plugin Jepettp [78].
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Network Reduction
In order to extract a representative core regulatory model from the initial network and to obtain a
more computationally tractable one, which reasonably unfolds the regulatory pathways, a reduction
methodology was followed based on certain simplifying assumptions – supported by previous results
in molecular biology studies – and on mathematical results from dynamical systems and graph
theory. Here we briefly describe the main steps. The step–by–step reduction process is included in
Text S1.
Simplifying assumptions:
• ESE-2 groups activities of ESE-1, ESE-3, EGF, Her-2/neu.
• Snai2 groups activities of Snail, Twist (Twist, in turn, groups activities of Twist1 and Twist2),
Zeb and FOXC2.
• p16 groups p14 and NF–κB node groups the inflammatory response activated by growth
factors, mitogens and cytokines.
Reduction process: (1) Simple mediator nodes (i.e., those nodes with in–degree and out–degree
of one) were removed iteratively. (2) Nodes with in–degree of one and out–degree greater than one
were removed iteratively. These steps (1 and 2) does not alter the attractors of the Boolean network
under the asynchronous update, as mathematically proved in [79]. (3) Redundant interactions of
selected nodes (based on biological arguments) resulting in self–regulation were included in single
nodes/interactions (for details, see Text S1). (4) Selected nodes (based on biological knowledge
again) with in–degree greater than one and out–degree of one were removed. The final steps (3
and 4) are supported by the mathematical analysis made in [80] in which the authors prove that
the methodology preserves relevant topological and dynamical properties.
It is noteworthy that fixed point attractors are time–independent, so they are the same in both
synchronous and asynchronous update methods. Complex attractors (in which the system oscillates
among a set of states), on the other hand, depend on the update method. Consistently, the
update method used in the model is irrelevant for the obtained results. This last assertion is
valid because the model shows only fixed point attractors, which means, under the mathematically
proved reduction methods applied, that the large network describes a qualitative long time behavior
conserved in the reduced one. Besides, the methodology applied in order to obtain the reduced
network enables the analysis of a resulting regulatory graph which is biologically meaningful and
dynamically consistent with the network constructed with available molecular biology experimental
data.
The final reduced network is shown in Figure 2. We refer to this network and its corresponding
logical rules as the core regulatory module.
Dynamical Gene Regulatory Network Model
A Boolean network models a dynamical system assuming both discrete time and discrete state
variables. This is expressed formally with the mapping:
xi(t+ 1) = Fi(x1(t), x2(t), ..., xk(t)), (1)
where the set of functions Fi are logical prepositions (or truth tables) expressing the relationship
between the genes that share regulatory interactions with the gene i, and where the state variables
xi(t) can take the discrete values 1 or 0 indicating whether the gene i is expressed or not at a
certain time t, respectively. An experimentally grounded Boolean GRN model is then completely
specified by the set of genes proposed to be involved in the process of interest and the associated
set of logical functions derived from experimental data [23]. The set of logical functions for the core
regulatory module used in this study is included in Text S1 – both as logical prepositions and truth
tables. The dynamical analysis of the Boolean network model was conducted using the package
BoolNet [63] within the R statistical programming environment (www.R-project.org).
Epigenetic Landscape Exploration
Including Stochasticity
In order to extend the Boolean Network into a discrete stochastic model and then study the
properties of its associated EL, the so–called stochasticity in nodes (SIN) model was implemented
following [23–25]. In this model, a constant probability of error ξ is introduced for the deterministic
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Boolean functions. In other words, at each time step, each gene “disobeys” its Boolean function
with probability ξ. Formally:
Pxi(t+1)[Fi(xregi(t))] = 1− ξ,
Pxi(t+1)[1− Fi(xregi(t))] = ξ.
(2)
The probability that the value of the now random variable xi(t + 1) is determined or not by its
associated logical function Fi(xregi(t)) is 1− ξ or ξ, respectively.
Attractor Transition Probability Estimation
An attractor transition probability matrix Π with components:
piij = P (At+1 = j|At = i), (3)
representing the probability that an attractor j is reached from an attractor i, was estimated by
numerical simulation following [24]. Specifically, for each network state i in the state space (2n) a
stochastic one–step transition was simulated a large number of times (≈ 10, 000). The probability
of transition from an attractor i to an attractor j was then estimated as the frequency of times the
states belonging to the basin of the attractor i were stochastically mapped into a state within the
basin of the attractor j.
Following the discrete time Markov chains (DTMCs) [81] theoretical framework, the estimated
transition probability matrix was integrated into a dynamic equation for the probability distribu-
tion:
PA(t+ 1) = ΠPA(t), (4)
where PA(t) is the probability distribution over the attractors at time t, and Π is the transition
probability matrix. This equation was iterated to simulate the temporal evolution of the probability
distribution over the attractors starting from a specific initial probability distribution.
Attractor Relative Stability and Global Ordering Analyses
In addition to the calculation of the most probable temporal cell–fate pattern (see [24]), a discrete
stochastic GRN model enables the study of the ease for transitioning from one attractor to another
[69]. Specifically, a transition barrier in the EL epitomizes the ease for transitioning from one
attractor to another. The ease of transitions, in turn, offers a notion of relative stability. It has
recently been proposed that the GRN has a consistent global ordering of all cell attractors and
intermediate transient states which can be uncovered by measuring the relative stabilities of all
the attractors of a Boolean GRN [64, 69]. Here, the relative stabilities of the cell states were
defined based on the mean first passage time (MFPT). Specifically, a relative stability matrix M
was calculated which reflects the transition barrier between any two states based on the MFPT.
Here, in all cases, the MFPT was estimated numerically. Using the transition probabilities among
attractors, a large number sample paths of a finite Markov chain were simulated. The MFPT from
attractor i to attractor j corresponds to the averaged value of the number of steps taken to visit
attractor j for the fist time, given that the entire probability mass was initially localized at the
attractor i. The average is taken over the realizations. Following [69], based on the MFPT values
a net transition rate between attractor i and j can be defined as follows:
di,j =
1
MFPTi,j
− 1
MFPTj,i
(5)
This quantity effectively measures the ease of transition as a net probability flow. For all the cal-
culation involving stochasticity, the robustness of the results was assessed by taking three different
values for the probability of error (0.01, 0.05, 0.1). Stability of the results was assessed by manually
changing the number of simulated samples until results become stable.
The consistent global ordering of all attractors uncovered with the core GRN was defined based
on the formula proposed in [64]. Briefly, the consistent global ordering of the attractors is given by
the attractor permutation in which al transitory net transition rates from an initial attractor to a
final attractor are positive. This is schematically represented in Figure 4b. Calculated transition
probability, MFPT, and net transition rate matrices are included in Text S2. R source code
implementing all the calculations and analyses is available upon request.
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Tables
KEGG – Pathway or Process XD–score q-value Overlap/Size
Bladder cancer 1.1447 0 12/38
Chronic myeloid leukemia 0.86866 0 17/69
p53 signaling pathway 0.78477 0 14/62
Pancreatic cancer 0.68155 0 14/70
Glioma 0.68155 0 12/60
Non–small cell lung cancer 0.66586 0 10/51
Melanoma 0.65574 0 12/62
Small cell lung cancer 0.56447 0 14/82
Prostate cancer 0.54821 0 14/84
Cell cycle 0.54821 0 20/120
Cytosolic DNA–sensing pathway 0.48155 0.00001 6/40
Thyroid cancer 0.36155 0.00784 3/25
NOD-like receptor signaling pathway 0.35612 0.00001 7/59
GO Biological Process XD-score q–value Overlap/Size
replicative senescence 3.13328 0 8/10
cellular senescence 0.73328 0.02244 2/10
cell aging 0.43328 0.00608 3/24
activation of NF–κB–inducing kinase activity 0.43328 0.04656 2/16
determination of adult lifespan 0.33328 0.40382 1/10
epithelial cell differentiation 0.32721 0.13188 2/33
positive regulation of NF–κB transcription factor activity 0.30109 0 8/87
Table 1: Significant pathways and processes according to network–based gene set en-
richment analysis
Cellular Phenotype Recovered Attractor (Active) “Expected Attractors” References
Epithelial Ese–2, NF-κB, E2F, Cyclin Ese–2, NF–κB, Cell Cycle(+) [29]
Senescent p16, p53, Ese–2, NF–κB, Rb p16, p53, NF–κB, Cell Cycle(-) [42,82,83]
Mesenchymal stem-like Snai2, Telomerase, NF–κB, Cyclin Snai2, Telomerase, NF–κB, Cell Cycle(+) [29,42]
Table 2: Predicted and Observed Attractors
Figure Legends
Figure 1. Gene regulatory network for epithelial carcinogenesis. Nodes represent genes,
and arrows (bars) represent experimentally characterized activation (arrow-heads) or repression
(flat-heads) interactions. Genes corresponding to TFs are represented by squares and the rest by
circles. (a) Colors indicate association with specific phenotypes and processes: epithelial (green),
mesenchymal (orange), inflammation (red), senescence and DNA damage (blue), cell–cycle (purple),
and polycomb complex (yellow). (b) Core gene regulatory module in the context of the global
16
network. Colored nodes represent the final set of molecules obtained after the network reduction
methodology was applied (see Methods) and which were included in the core GRN model.
Figure 2. Core gene regulatory network module for epithelial carcinogenesis Nodes
represent either single or subsets of genes (see Results); arrows-heads represent activations and
flat–heads repression interactions. Five of the nodes are involved in the specification of the cellular
phenotypes: Epithelial (Ese–2), Senescent (p16, p53), and Mesenchymal stem–like (Snai2, TELasa).
Three nodes are tightly associated with cell–cycle regulation (Rb, E2F, Cyclin), while node NF–κB
represents cellular inflammation.
Figure 3. The core gene regulatory module in the context of the Hallmarks of Cancer ap-
proach. The antagonistic activity state ESE–2 (-) and Snai2 (+) enable cells to sustain proliferative
signals and evade growth suppressors by undergoing a dedifferentiation process. The state p16(-),
Rb(-), p53(-), and TELasa (+) enable cell to acquire replicative immortality, resist cell death, as
well as present genome instability and a mutation–prone phenotype by surpassing cellular senes-
cence. High levels of cytokines and NF–κB(+) expose cells to tumor promoting inflammation. The
constitutive activity of Snai2(+) epitomizes the intrinsic phenotypic features of the cells emerging
from the process of inflammation–induced EMT: activating invasion, avoiding immune destruction,
and deregulating cellular energetics.
Figure 4. Temporal sequence and global order of cell–fate attainment pattern un-
der the stochastic Boolean GRN model during epithelial carcinogenesis. (a) Maximum
probability p of attaining each attractor, as a function of time (in iteration steps). Vertical lines
mark the time when maximal probability of each attractor occurs. The most probable sequence
of cell attainment is: epithelial(E) → senescent(S) → mesenchymal(cancer–like)(M). The value of
the error probability used in this case was ξ = 0.05. The same patterns were obtained with the 3
different error probabilities tested (data not shown). (b) Schematic representation of the possible
transitions between pairs of attractors. Arrows indicate the directionality of the transitions. Above
each arrow a sign (+) or (−) indicates whether the calculated net transition rate between the cor-
responding attractors is positive or negative. Red arrows represent the globally consistent ordering
for the 3 attractors: the order of the attractors in which all individual transition has a positive net
rate, resulting in a global probability flow across the EL.
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Figure 1: Gene regulatory network for epithelial carcinogenesis.
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Figure 4: Temporal sequence and global order of cell–fate attainment pattern under the stochastic Boolean
GRN model during epithelial carcinogenesis.
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